Holger Amthauer

ORCID: 0000-0003-4414-0657
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Medical Imaging Techniques and Applications
  • Radiomics and Machine Learning in Medical Imaging
  • Radiopharmaceutical Chemistry and Applications
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Neuroendocrine Tumor Research Advances
  • Neuroblastoma Research and Treatments
  • Lung Cancer Research Studies
  • Lung Cancer Diagnosis and Treatment
  • Advanced MRI Techniques and Applications
  • Medical Imaging and Pathology Studies
  • MRI in cancer diagnosis
  • Lymphoma Diagnosis and Treatment
  • Prostate Cancer Treatment and Research
  • Lung Cancer Treatments and Mutations
  • Pancreatic and Hepatic Oncology Research
  • Glioma Diagnosis and Treatment
  • Advanced X-ray and CT Imaging
  • Advanced Radiotherapy Techniques
  • Cancer, Hypoxia, and Metabolism
  • Radiation Dose and Imaging
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Functional Brain Connectivity Studies
  • Colorectal Cancer Treatments and Studies
  • Renal cell carcinoma treatment
  • Cardiac Imaging and Diagnostics

Charité - Universitätsmedizin Berlin
2016-2025

Humboldt-Universität zu Berlin
2004-2025

Freie Universität Berlin
2004-2025

Klinik und Poliklinik für Nuklearmedizin
2013-2025

University Hospital Magdeburg
2012-2023

Otto-von-Guericke University Magdeburg
2009-2023

Max Delbrück Center
2022-2023

KU Leuven
2023

Auguste-Viktoria-Klinik
2022

Society of Interventional Radiology
2016-2022

The objective of this study was to evaluate the impact positron emission tomography (PET) using fluorine-18-fluorodeoxyglucose (FDG) for initial staging and therapy planning in pediatric sarcoma patients.In prospective multicenter study, 46 patients (females, n = 22; males, 24; age range, 1 18 years) with histologically proven (Ewing family tumors, 23; osteosarcoma, 11; rhabdomyosarcoma, 12) were examined conventional imaging modalities (CIMs), including ultrasound, computed (CT), magnetic...

10.1200/jco.2007.12.2473 article EN Journal of Clinical Oncology 2007-11-29

In patients with liver malignancies potentially amenable to curative extended right hepatectomy but insufficient size of the future remnant (FLR), portal vein embolization (PVE) tumor-bearing is used induce contralateral hypertrophy leaves tumor untreated. Radioembolization (RE) treats in embolized lobe along induction. We performed a matched-pair analysis compare capacity for induction these two modalities. Patients right-hepatic secondary no or negligible left-hepatic involvement who were...

10.1002/hep.26947 article EN Hepatology 2013-11-21

Purpose In adult Hodgkin's lymphoma (HL) risk stratification after early therapy response assessment with [ 18 F]fluorodeoxyglucose (FDG) positron emission tomography (PET) seems to allow tailoring less toxicity for patients adequate metabolic response. This study delivers the first prospective data on potential of FDG-PET in pediatric HL. Patients and Methods was performed 40 HL before polychemotherapy (PET-1), two cycles (PET-2), completion (PET-3). Mean follow-up 46 months (range, 26 72...

10.1200/jco.2008.19.7814 article EN Journal of Clinical Oncology 2009-08-11

<i>Aim:</i> Retrospective evaluation of the impact integrated positron emission tomography/computed tomography (PET/CT) using <sup>68</sup>Ga-DOTA(0)-Phe(1)-Tyr(3)-octreotide (<sup>68</sup>Ga-DOTATOC) on therapeutic management patients with neuroendocrine tumors (NET). <i>Methods:</i> The <sup>68</sup>Ga-DOTATOC-PET/CT data 66 (31 male, 35 female; age: 29–79, mean 56 years) known or suspected NET were included. Imaging (PET and...

10.1159/000265561 article EN Neuroendocrinology 2009-12-09

Purpose Currently, a routine bone marrow biopsy (BMB) is performed to detect (BM) involvement in pediatric Hodgkin's lymphoma (HL) stage greater than IIA. [ 18 F]fluorodeoxyglucose positron emission tomography (FDG-PET) increasingly used for the initial staging of HL. The value using FDG-PET BM has not been sufficiently defined. We compared results BMBs and diagnosis large group with Patients Methods 175 patients newly diagnosed classical HL IIA was determined by BMB, FDG-PET, chest computed...

10.1200/jco.2010.32.4996 article EN Journal of Clinical Oncology 2011-08-09

JAK2-V617F–positive chronic myeloproliferative neoplasia (CMN) commonly displays dysfunction of integrins and adhesion molecules expressed on platelets, erythrocytes, leukocytes. However, the mechanism by which 2 major leukocyte integrin chains, β1 β2, may contribute to CMN pathophysiology remained unclear. (α4β1; VLA-4) β2 (αLβ2; LFA-1) are essential regulators for attachment leukocytes endothelial cells. We here showed enhanced granulocytes from mice with JAK2-V617F knockin (JAK2+/VF mice)...

10.1172/jci90312 article EN Journal of Clinical Investigation 2018-07-19

We evaluated whether the artificial intelligence chatbot ChatGPT can adequately answer patient questions related to [<sup>18</sup>F]FDG PET/CT in common clinical indications before and after scanning. <b>Methods:</b> Thirteen regarding were submitted ChatGPT. was also asked explain 6 reports (lung cancer, Hodgkin lymphoma) follow-up (e.g., on tumor stage or recommended treatment). To be rated "useful" "appropriate," a response had adequate by standards of nuclear medicine staff....

10.2967/jnumed.123.266114 article EN cc-by Journal of Nuclear Medicine 2023-09-14

PURPOSE: To prospectively assess accuracy of magnetic resonance (MR) imaging, MR cholangiopancreatography (MRCP), and angiography in patients suspected having pancreatic tumors. MATERIALS AND METHODS: Sixty-six tumors underwent imaging (unenhanced contrast material–enhanced MR, MRCP, contrast-enhanced angiography). Two blinded readers analyzed the images by consensus, results were correlated with surgery, biopsy, or follow-up findings. Results tabulated two-by-two tables. RESULTS: assessment...

10.1148/radiol.2241010798 article EN Radiology 2002-07-01

To determine the value of single photon emission computed tomography (SPECT) with integrated low-dose (CT) for interpretation inconclusive foci in planar I whole-body scans after radioiodine therapy.Twenty-five patients findings scanning ablative therapy (3.7 GBq I) due to differentiated thyroid cancer were included. SPECT/CT region question was performed Millennium VG Hawkeye (GE Medical Systems). SPECT and without CT fusion evaluated by two blinded independent nuclear medicine physicians a...

10.1097/00006231-200412000-00004 article EN Nuclear Medicine Communications 2004-11-10

The diagnostic value of neuroendocrine tumor (NET) imaging using PET with integrated CT is dependent on both components. This retrospective study assessed the single phases a triple-phase (early arterial, portal-venous inflow, and venous) protocol in comparison to (68)Ga-DOTATOC masked reading.(68)Ga-DOTATOC PET/CT examinations from 51 patients known or suspected NET were included. Two readers data each 3 for lesions independently (using 3-point score: 1 = benign, 2 indeterminate, malignant)...

10.2967/jnumed.110.083741 article EN Journal of Nuclear Medicine 2011-04-15

<sup>90</sup>Y radioembolization is a promising therapy for patients with primary and secondary liver malignancies. Pretherapeutic assessment consists of hepatic angiography <sup>99m</sup>Tc-macroaggregated albumin (<sup>99m</sup>Tc-MAA) perfusion scintigraphy to estimate the liver-to-lung shunt exclude extrahepatic <sup>99m</sup>Tc-MAA deposition. However, predictive value intratumoral uptake remains unclear. <b>Methods:</b> One hundred four chemotherapy-refractory liver-dominant metastatic...

10.2967/jnumed.112.112508 article EN Journal of Nuclear Medicine 2013-02-27
Coming Soon ...